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Contagious caprine pleuropneumonia (CCPP) is a highly contagious disease caused byMycoplasma capricolum subsp. capri-
pneumoniae that affects goats in Africa and Asia. Current available methods for the diagnosis ofMycoplasma infection, includ-
ing cultivation, serological assays, and PCR, are time-consuming and require fully equipped stationary laboratories, which make
them incompatible with testing in the resource-poor settings that are most relevant to this disease. We report a rapid, specific,
and sensitive assay employing isothermal DNA amplification using recombinase polymerase amplification (RPA) for the detec-
tion ofM. capricolum subsp. capripneumoniae. We developed the assay using a specific target sequence inM. capricolum subsp.
capripneumoniae, as found in the genome sequence of the field strain ILRI181 and the type strain F38 and that was further evi-
denced in 10 field strains from different geographical regions. Detection limits corresponding to 5 103 and 5 104 cells/ml
were obtained using genomic DNA and bacterial culture fromM. capricolum subsp. capripneumoniae strain ILRI181, while no
amplification was obtained from 71 relatedMycoplasma isolates or from the Acholeplasma or the Pasteurella isolates, demon-
strating a high degree of specificity. The assay produces a fluorescent signal within 15 to 20 min and worked well using pleural
fluid obtained directly from CCPP-positive animals without prior DNA extraction. We demonstrate that the diagnosis of CCPP
can be achieved, with a short sample preparation time and a simple read-out device that can be powered by a car battery, in<45
min in a simulated field setting.
Contagious caprine pleuropneumonia (CCPP) is one of themost severe diseases affecting goats throughout eastern Africa
and many parts of Asia. CCPP is caused by Mycoplasma capri-
colum subsp. capripneumoniae (1), which belongs to the Myco-
plasma mycoides cluster, comprising four additional closely re-
latedmycoplasmas (M. capricolum subsp. capricolum,M.mycoides
subsp. capri, M. mycoides subsp. mycoides, and Mycoplasma
leachii), all organisms which cause diseases in ruminants (2, 3).
CCPP is associated with major financial losses for goat producers
and imposes trade restrictions on live animals (4). The disease is
characterized by fever (41°C), coughing, and respiratory distress
and is associated with morbidity and mortality approaching 90%
and 60%, respectively (1).Macroscopic lesions of pleuropneumo-
nia are often unilateral, and a very high production of pleural fluid
is frequently observed postmortem (5). The clinical signs of CCPP
may be confused with infections caused by otherMycoplasma spp.
or Pasteurella spp. The current option for containing CCPP out-
breaks is vaccination with a bacterin-type of vaccine (6). Prompt
diagnosis is crucial for effective disease control and monitoring.
However, the spread and burden of CCPP remain largely un-
known, mainly due to inadequately funded veterinary services, an
absence of infrastructure enabling swift sample transport, and the
lack of rapid, inexpensive, sensitive, and specific diagnostic tests
applicable for field use. Recently, a competitive enzyme-linked
immunoassay (cELISA) for CCPP was modified to create a heat-
stable laboratory diagnostic kit suitable for prevalence and vaccine
efficacy screening; however, it is not suitable for detecting acute
disease in the field (7). Thus, for diagnosing CCPP, the gold stan-
dard remains the direct isolation and cultivation ofM. capricolum
subsp. capripneumoniae from infected lung tissues or pleural fluid
collected postmortem. However, the process is cumbersome and
time-consuming due to the fastidious nature of this bacterium. In
addition, bacterial isolationmay be hampered by sample contam-
ination and prior antibiotic treatment of the diseased animals.
Moreover, DNA-based confirmation of the cultures using PCR
methods (8–10) is still needed. Thus, culture, isolation, and mo-
lecular characterization ofM. capricolum subsp. capripneumoniae
is not feasible for rapid containment of a CCPP outbreak. A latex
agglutination test (11) has been developed for field diagnosis of
CCPP, based on the detection of serum antibodies against poly-
saccharide antigens. Although rapid and applicable for field use,
this test is not specific for M. capricolum subsp. capripneumoniae
(12). Alternatively, advanced molecular techniques, such as real-
time PCR, are both sensitive and specific (10). However, methods
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such as these require awell-equipped laboratory, expensive equip-
ment, and trained personnel. A loop-mediated isothermal ampli-
fication (LAMP) assay for the detection of M. capricolum subsp.
capripneumoniae has been reported recently (13). This assay tran-
scends the limitations associated with thermocyclers; however, it
still requires DNA extraction protocols and gel electrophoresis to
separate DNA products on horizontal agarose gels, which limits
the applicability of this method as a field test. Recombinase poly-
merase amplification (RPA) is another isothermal technique for
detecting DNA (14). RPA employs recombinase-driven oligonu-
cleotide binding to a template sequence followed by DNA poly-
merase-facilitated strand extension. DNA amplification can be
monitored in real time using a sequence specific fluorescent probe
that fluoresces upon binding to an amplicon. This technique of-
fers high sensitivity comparable to traditional PCR with the ad-
vantage that double-stranded DNA is exponentially amplified at
constant and low temperatures (optimal temperature range, 37°C
to 42°C). RPA-based diagnostic assays have been described for
pathogen detection direct from biological samples, including
urine samples (15). Here, we describe the development of a spe-
cific and sensitive assay using RPA for the rapid diagnosis of CCPP
directly from clinical caprine specimens (i.e., pleural fluid and
lung tissue samples).We demonstrate that this assay is suitable for
field testing using lyophilized test reagents, a car battery for power,
and a portable fluorescent illuminator to read the assay output.
MATERIALS AND METHODS
RPA primer and probe design.The full genome sequence ofMycoplasma
capricolum subsp. capripneumoniae strain ILRI181, isolated during a re-
cent outbreak in Kenya (EMBL accession no. LN515399) (16), was used
for primer and probe design. Oligonucleotides were designed according
to the TwistDx guidelines (TwistDx, United Kingdom). The in silico spec-
ificities of the primers and probe were investigated using the pattern-
searching tool fuzznuc from the EMBOSS package (17) against selected
bacterial genomes: Mycoplasma capricolum subsp. capripneumoniae, My-
coplasma mycoides subsp. mycoides, Mycoplasma mycoides subsp. capri,
Mycoplasma capricolum subsp. capricolum, Mycoplasma leachii, Myco-
plasma putrefaciens, Mycoplasma bovis, Mycoplasma bovigenitalium, My-
coplasma arginini, Mycoplasma californicum, Mycoplasma alkalescens,
Mycoplasma canis, Acholeplasma laidlawii, Pasteurella multocida, and
Mannheimia haemolytica. Parameterswere set to check for both the strand
and the complementary strand on a circular molecule allowing 1, 5, and
10 mismatches (fuzznuc -complement -scircular -pmismatch 1, 5 or 10).
The output gff file was converted to an Excel sheet by a custom script. The
M. capricolum subsp. capripneumoniae-specific oligonucleotides were
synthesized by Integrated DNA Technologies (USA), while the probes
containing the flourophore 6-carboxyfluorescein (6-FAM) (thymidine
nucleotide carrying fluorescein [dT-FAM]), a tetrahydrofuran spacer
(THF), a quencher (thymidine nucleotide carrying black hole quencher 1
[dT-BHQ1]), and a 3= block (C3-spacer) were synthesized by Biosearch
Technologies, Inc. (USA).
Mycoplasma strains and growth conditions. For the optimization
and evaluation of the RPA, M. capricolum subsp. capripneumoniae strain
ILRI181 was used. Eighty-five additional strains representing 25 species
and subspecies were included to investigate the specificity of the RPA (see
Table S1 in the supplemental material). All strains were cultured in my-
coplasma liquid medium (Mycoplasma Experience, Ltd., United King-
dom) at 37°C for 24 h to 72 h until a color change from red to orange was
observed. Aliquots ofM. capricolum subsp. capripneumoniae ILRI181 cells
were stored at 80°C until further use in spiking experiments. Color
change units per milliliter (CCU/ml) (18) were determined in duplicates
for strain M. capricolum subsp. capripneumoniae ILRI181 by making 10-
fold dilutions of the culture inmycoplasma liquidmedium. The dilutions
were grown at 37°C for 1 week prior to determining the CCU/ml.
Isolation of genomic DNA. Bacterial strains were grown in myco-
plasma liquid medium, as described above. Cultures (10 ml) were centri-
fuged, the supernatants were discarded, and the cell pellets were resus-
pended in 500 l of TNE buffer (10 mM Tris-HCl, pH of 8.5; 10 mM
NaCl; 10 mM EDTA). Afterward, 10 l SDS 10% and 10 l proteinase K
(20 mg/ml) was added, and the cell suspensions were incubated at 37°C
for 2 h. Thereafter, 52l phenylmethylsulfonyl fluoride (PMSF) (100mM
in ethyl alcohol [EtOH], stored at 20°C) was added, followed by an
additional incubation at room temperature for 15 min. Following the
addition of 50l RNase A (10 mg/ml), the suspensions were incubated at
37°C for 1 h. Then 50 l sodium acetate (1.5 M, pH of 5.2) and 550 l
buffered phenol were added; the solutions were mixed using a vortex
mixer and centrifuged at 14,000 g for 10 min (Centrifuge 5425, Eppen-
dorf, Germany). The top phasewas transferred to a new reaction tube; 550
l phenol-chloroform-isoamylalcohol (25/24/1) solution was added, and
the suspensions were vortexed for 20 s. Following an additional centrifu-
gation step (14,000 g for 10min), the top phase was transferred to a new
reaction tube, and the DNA was precipitated using isopropanol, washed
with 70% EtOH (19), air dried, and resuspended in 100 l Tris-HCl (10
mM, pH of 8.5). DNA concentrations (ng/l) were determined using
Nanodrop and Qubit instruments (both Thermo Fisher Scientific, Inc.).
Clinical specimens and optimization of sample preparation. The
RPAwas evaluated using a panel of pleural fluid samples (n 5) and lung
tissue specimens (n 2) collected from goats during a recent outbreak of
CCPP in Kenya in 2012 (Table 1).
Tenfold dilutions in liquid medium, as described above, were used to
determine the CCU/ml titer in the pleural fluid samples. Tissue samples
were also cultured in liquid media for 1 week, as described above, to
determine the presence ofMycoplasma isolates. As needed, the initial tis-
sue culture was filtered through a 0.22-m filter (Carl Roth, Germany)
before diluting the filtered material 1:10 in fresh medium prior to contin-
ued growth. We evaluated different methods for sample preparation (i.e.,
bacterial lysis, sample dilution, and template volume) for the RPAs in
duplicate on a subset of the pleural fluid samples (n 2) and on available
lung tissue samples (n 2). Pleural fluid samples were diluted 1:20 or 1:50
in either 10 mM Tris-HCl (pH of 8.0) or nuclease-free water for subse-
quent heat lysis (60°C for 10 min) or in 0.2 M potassium hydroxide
(KOH) or nuclease-free water for direct lysis. Five lung tissue samples
from each animal were cut into small pieces (125 mm3) using a scalpel.
The tissues were homogenized manually using a tissue grinder (Rotilabo;
Carl Roth, Germany) in 500 l of 10 mM Tris-HCl, 0.2 M KOH, or
nuclease-free water. Samples in nuclease-free water and 0.2 M KOHwere
not heated, while 10 mM Tris samples were heated at 60°C for 10 min.
Then, 1 or 5 l of the different lysates (pleural fluid/lung tissue homoge-
nate) was used as a template in a final reaction volume of 50 l for the
RPAs. After the sample preparation conditions had been optimized, the
remainders of the specimens were tested in duplicate using the most suit-
able method. In addition to the M. capricolum subsp. capripneumoniae-
positive samples described above, a panel of well-characterized M. capri-
TABLE 1 Pleural fluid and tissue samples collected during a 2012 CCPP
outbreak in Kenya
Sample source
Pleural fluid Lung tissue
CCU/ml RPA Culture RPA
Goat 092 107–108 Posa Pos Pos
Goat 181 109 Pos Pos Pos
Goat DOD 7-8/10 108–109 Pos NDb ND
Goat F 107–108 Pos ND ND
Goat Y 109 Pos ND ND
a Pos, positive.
b ND, not determined.
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colum subsp. capripneumoniae-negative archived caprine specimens, i.e.,
16 lung tissue specimens and one pleural fluid sample as well as pleural
fluid samples from cattle (n  2) experimentally infected with Myco-
plamsa mycoides subsp. mycoides (20), were included as negative clinical
controls (see Data Set S2 in the supplemental material). These samples
were processed using the most suitable method for sample preparation.
Optimization of laboratory-based RPAs. The RPA reactions were
performed using the reagents and protocols from the TwistAmp exo kit
(TwistDx, United Kingdom). Each 50-l reaction mixture contained the
following: 29.5 l rehydration buffer, 12.2 or 8.2 l nuclease-free water,
2.1l each of a forward primer/reverse primer (10mM), 0.6l probe (10
mM), and 1.0 or 5.0 l of template. The reagents were vortexed briefly
prior to dissolving the reaction pellet. To start the reaction, 2.5 l
magnesium acetate (MgOAc, 280 mM) was added to the cap of the
tube followed by a brief centrifugation (mini G; IKA, Germany), an-
other vortex, and a final brief centrifugation. Fluorescence was mea-
sured in an ESEQuant tube scanner (Qiagen, Germany) at 42°C every
30 s for 30 min in the FAM channel (excitation  470 nm, emission 
520 nm). We tested the effect of vortexing the assay 4 to 6 min after it
was initiated. To distinguish positive from negative results, a cutoff
value was calculated for every individual sample according to the
guidelines on threshold validation in the Twista Studio software man-
ual. A sample was deemed positive if all replicates were above three and
a half standard deviations (3.5 SD) of the background during a defined
time range (i.e., after 19 to 20 min of amplification). A threshold time
range of 0 to 4 min 30 s was used.
Optimization of field-applicable RPAs. RPA reaction pellets (Twist-
Amp exo kit) were dissolved in buffer, primer, probe, and water, as de-
scribed above but excluding template (5.0l) andMgOAc. Then, the RPA
reactions were frozen at80°C prior to lyophilisation in LyoQuest (Tel-
star life science solutions) at a temperature of 55°C and a pressure of
0.400 mBar. Aliquots of MgOAc (2.5l) were also lyophilized in separate
tubes. Aliquots of lyophilized RPA reactions andMgOAcwere either used
directly or stored at 4°C and 37°C for 5 days prior to use. In addition, a
subset of the lyophilized reactions was stored at 4°C for 3 months before
use. To set up the reactions, 5l template and 45l of nuclease-free water
was added to the lyophilized MgOAc, and this mixture was used to dis-
solve the lyophilized RPA reaction pellets. Immediately after dissolving
(i.e., t 0min), we performed a fluorescencemeasurement using the tube
scanner. The sensitivities of the lyophilized reactions were determined, as
described below, using cultured M. capricolum subsp. capripneumoniae
ILRI181 in spiking experiments. The read-out system (ESEQuant tube
scanner) was tested for field applicability by running the reactions in a car
using a DC-to-DC converter (120-W laptop car power supply [L40BB])
connected to a 12-V plug.
Determination of specificities of the M. capricolum subsp. capri-
pneumoniae primers/probe.The specificities of theM. capricolum subsp.
capripneumoniae primers and probe were determined by performing du-
plicate RPA reactions using genomic DNA (corresponding to 107 copies
of the genome) from a total of 86 bacterial strains (see Table S1 in the
supplemental material). Positive controls using 107 genome copies of M.
capricolum subsp. capripneumoniae ILRI181 DNA were included in each
run.
Determination of RPA sensitivity. The sensitivity of the RPA was
determined using genomic DNA (corresponding to 100 to 106 genome
copies/l) and lysed bacteria (corresponding to 100 to 105 CCU/ml) ofM.
capricolum subsp. capripneumoniae ILRI181 in spiking experiments. Ev-
ery run was repeated 8 times. The DNA was diluted 10-fold in nuclease-
free water, and bacteria were diluted 10-fold in plasma (resembling pleu-
ral fluid) isolated from a healthy goat prior to a 100-fold dilution in
nuclease-free water for direct lysis. Five l of template DNA was used
from each dilution in a total RPA reaction volume of 50l. Nuclease-free
water and plasma diluted 1:100 in nuclease-free water were included in
every run as negative controls for the DNA and spiking experiments,
respectively.
Assessment of RPA performance using pleural fluid and lung tissue
specimens. Pleural fluid samples (n  6) were diluted 1:50 in nuclease-
free water, and 5 l of this dilution was used as the template for the RPA
amplification. Lung tissue specimens (n 18) were homogenized manu-
ally in 500l of 0.2MKOH. Onel of the tissue homogenate was used as
a template in a final reaction volumeof 50l for theRPAs. These reactions
were performed in duplicate.
RESULTS
In silico specificities of primers and probe for RPA. The primers
were designed to amplify a 245-bp region within a single-copy
gene in the genome of M. capricolum subsp. capripneumoniae
strain ILRI181 (locus tag MCCPILRI181_00726) (16) (Table 2).
To ensure that the target sequences were unique toM. capricolum
subsp. capripneumoniae, we screened the selected primers and
probe in silico against the genomes of 14 bacteria causing infec-
tions in ruminants (see Data Set S1 in the supplemental material).
We were unable to find complementary regions when allowing 1
or 5 sequencemismatches for the primer sequences. Permitting 10
mismatches did give rise to sequence matches for one of the two
primers. According to this in silico analysis, the primers fulfilled
the requirements to ensure specificity of the RPA technology (21).
Sample preparation optimization. We evaluated various
methods for sample preparation for the RPAs. Direct lysis of pleu-
ral fluid specimens (n  2) in nuclease-free water was sufficient
for release of nucleic acids from mycoplasma. We did not find a
significant difference in signal intensity and onset of the RPA re-
action between samples lysed in a 1:20 or 1:50 dilution in H2O,
Tris-HCl, or KOH. Heat lysis of bacteria at 60°C for 10 min in
nuclease-free water or Tris-HCl buffer (10 mM, pH of 8.5) and
alkaline lysis in 0.2 M KOH reduced fluorescent signal intensities
(mV) and delayed the onset of the reaction (data not shown).
Subsequently, RPA reactions with pleural fluid samples were per-
formed using direct lysis in nuclease-free water in a dilution of
1:50. Similar methods of bacterial lysis were also evaluated for
lung tissue samples (n 2). We tested five lung tissue specimens
from each animal and found considerable variability in detecting
Mycoplasma isolates in the tissue specimens used. All five speci-
mens produced a positive M. capricolum subsp. capripneumoniae
result; however, there were differences in signal intensity. Positive
results were obtained within 10 to 14 min when bacterial lysis was
performed using 0.2 M KOH and 1 l lysate (see Fig. S1 in the
supplemental material). Similar results were obtained when 5 l
of sample was used; the concentration of KOH had a negative
impact on the appearance of fluorescence in the assay (data not
shown). Direct lysis of bacteria in nuclease-free water and heat
lysis in Tris-HCl buffer did not improve the signal intensity.
Specificity of the RPA reaction. To assess the specificity of the
M. capricolum subsp. capripneumoniae RPA reaction, genomic
TABLE 2 Oligonucleotide primers and probe used in this study
Oligonucleotidea Sequence (5= to 3=)
Mccp_F AATCGGTTTATCAAGCCATTCGACATTCTATAAAAT
Mccp_R GAAAATTAAACTTTGAAAGAAATAGAATTTAGTTT
Mccp_P CTCTCTTTTATCACTAACAAAATTCAAAAAGA
[dT-FAM][THF][dT-BHQ1]CCTTTAAGTCATAAAA
[3=-block]b
a F, forward primer; R, reverse primer; P, probe.
b dT-FAM, thymidine nucleotide carrying fluorescein; THF, tetrahydrofuran spacer;
dT-BHQ1, thymidine nucleotide carrying black hole quencher 1.
Liljander et al.
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DNA samples from a panel of Mycoplasma spp. and non-Myco-
plasma spp. ruminant bacterial pathogens were tested (see Table
S1 in the supplemental material). As expected, amplification was
obtained only when template DNA from M. capricolum subsp.
capripneumoniae strains was used. All 14 M. capricolum subsp.
capripneumoniae strains tested produced a positive assay signal.
All of the 71 non-M. capricolum subsp. capripneumoniae strains, as
well as the negative controls, remained negative throughout the
30-min analysis period.
Molecular sensitivity of theRPA reaction.The detection limit
of the RPA reaction was assessed using 10-fold dilutions of
genomic DNA extracted from M. capricolum subsp. capripneu-
moniae ILRI181. Eight reactions were performed for each DNA
dilution. An example of the output is shown in Fig. 1A. We de-
tected high DNA concentrations (5  106 to 5  105 genome
copies/reaction) within 7 min of amplification and reproducibly
detected 50 to 500 genome copies/reaction within 15 min. We
determined the overall assay sensitivity by assaying 10-fold dilu-
tions of cultured M. capricolum subsp. capripneumoniae strain
ILRI181 diluted in goat plasma. Figure 1B depicts a representative
example of the assay output. At high bacterial concentrations (i.e.,
500 CCU/reaction), we detected an increase in the fluorescent
signals (mV)within 10min of amplification, while concentrations
of 50 CCU/reaction were detected within 15 min. Bacterial con-
centrations of 5 CCU/reactionwere consistently detected, albeit at
low signal intensities. An additional mixing of the reaction by
including a short vortexing step after 4 to 6 min did not improve
the sensitivity or signal intensity (data not shown).
RPA performance using clinical specimens from a recent
Kenyan CCPP outbreak. We evaluated the RPA using pleural
fluid samples (n  5) and lung tissue samples (n  2) collected
during a CCPP outbreak in Kenya in 2012. All clinical specimens
were cultured to determine presence of Mycoplasma isolates
and/or CCU/ml titers. All but one replicate of the tissue cultures
contained detectableMycoplasma isolates. Bacterial titers ranging
between 107 to 109 CCU/mlwere obtained frompleural fluid sam-
ples cultured in duplicate (Table 1).We found that all pleural fluid
samples produced positive assay results within 10 to 13 min after
initiating the RPA reaction. An example of a sample curve from a
pleural fluid sample is depicted in Fig. 2. (See Fig. S1 in the sup-
plementalmaterial for examples of the data from the lung tissues.)
All included archivedM. capricolum subsp. capripneumoniae-neg-
ative clinical specimens were negative in the RPA (see Data Set S2
in the supplemental material).
RPAperformance in a simulatedfield setting.To test the stor-
age conditions for the RPA reagents for field use, we lyophilized
theRPA reaction components andMgOAc and stored themat 4°C
and 37°C. Immediately prior to performing the RPAs, we dis-
solved lyophilizedMgOAc pellets (2.5 l) in a solution consisting
of 5l template (culturedM. capricolum subsp. capripneumoniae)
in 45 l of nuclease-free water, and we added this solution to the
lyophilized RPA reactions. The results indicated that 37°C is not a
suitable temperature for storing lyophilized RPA reactions and
MgOAc. We were not able to detect fluorescence signals using
lyophilized RPA reagents stored at 37°C for 5 days, even when
using fresh solutions of MgOAc. We were also unable to detect
positive assays when we used freshly prepared solutions of RPA
reagents and lyophilized MgOAc stored at 37°C. We found that
lyophilized RPA reactions and MgOAc can be stored at 4°C for 5
days with acceptable compromise of the reaction signals com-
pared with fresh RPA reactions. We determined the reaction sen-
sitivity for lyophilized RPA andMgOAc stored at 4°C by culturing
M. capricolum subsp. capripneumoniae ILRI181 and spiking the
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B
200
400
1,400
1,200
1,000
800
600
Time (min)
Int
(mV)
5 2010 15 25 30
5x1005x1015x1035x1045x1055x106 5x102
200
400
1,400
1,200
1,000
800
600
1,600
Int
(mV)
Time (min)
H2O
0.5
CCU
5
CCU
50
CCU
500
 CCU
plasma
A
FIG 1 Graph depicting the RPA amplification (development of fluorescence,
mV) over time (minutes). (A) M. capricolum subsp. capripneumoniae DNA
(5  106 to 5  100 copies/reaction) diluted in nuclease-free water. (B) M.
capricolum subsp. capripneumoniae CCU (500 to 0.5 CCU/reaction) spiked in
plasma from a healthy goat. Each graph represents the mean value from eight
individual runs.
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FIG 2 Graph depicting the amplification from pleural fluid samples from a
CCPP-infected animal (Goat 181) in duplicate. Negative control, nuclease-
free water.
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bacterium into experiments. We found a detection limit of 50
CCU/reaction in triplicate runs, which is10-fold less than that
in assays using fresh RPA reactions. The same results were ob-
tained after storing lyophilized RPA andMgOAc pellets at 4°C for
3months. A detection system based on an ESEQuant tube scanner
powered using a 120-W laptop car power supply (L40BB) con-
nected to a car cigarette lighter worked well for measuring the
assay output (see Fig. S2 in the supplemental material).
DISCUSSION
Successful surveillance and control of livestock diseases requires
specific, sensitive, and rapid diagnosis of pathogens. In developed
countries, laboratory-based tests, such as ELISA and real-time
PCR, are useful for making rapid diagnoses, in part due to wide-
spread clinical labs, networks of diagnostic laboratories, and cou-
rier systems that guarantee rapid transport of specimens to the
laboratory. The low prevalence of such laboratories and the ab-
sence of a similar network in many regions of sub-Saharan Africa
limit the feasibility of these clinical tests. Furthermore, infrastruc-
ture limitations (e.g., lack of reliable power and refrigeration)
complicate the development of field-adapted assays. In this study,
we developed a newdiagnostic assay based onRPA and assessed its
applicability to rapidly and robustly diagnose CCPP, one of the
major diseases affecting small ruminants in developing countries
in Africa and Asia.
The assay detected the pathogen Mycoplasma capricolum
subsp. capripneumoniae specifically and sensitively from labora-
tory samples (purified genomicDNA), cultured bacteria, and field
samples (pleural fluid from a CCPP outbreak). We demonstrated
the ability to correctly differentiate betweenM. capricolum subsp.
capripneumoniae and other closely related mycoplasmas and bac-
terial pathogens causing CCPP-like symptoms, which is a critical
step for this type of diagnostic assay. We achieved assay specificity
by engineering the RPA to reduce off-target binding and cross-
reactivity with other closely related Mycoplasma strains. No am-
plification was obtained from a large panel of DNA samples from
closely related Mycoplasma strains and other bacteria causing in-
fections in ruminants. In contrast, we were able to correctly iden-
tify DNA samples from 14M. capricolum subsp. capripneumoniae
strains using the assay, thereby demonstrating a high degree of
specificity. Amplification was detected within several minutes
when using DNA extracted by conventional methods, and with as
few as 50 genome copies. These results highlight RPA for diagnos-
tic detection of M. capricolum subsp. capripneumoniae in ex-
tractedDNA. To circumvent the need for nucleic acid purification
under field conditions, we evaluated several simple methods for
sample preparation, including direct bacterial lysis with nuclease-
free water, heat lysis, and alkaline lysis (0.2MKOH). The heat and
alkaline lyses alternatives did not result in sufficient recovery of
DNA from cultured material and pleural fluid samples, as dem-
onstrated by a delay and a low level of fluorescence produced (data
not shown).We found that direct bacterial lysis with nuclease-free
water worked well. Similar sensitivities were obtained from
plasma samples spiked with cultured M. capricolum subsp. capri-
pneumoniae compared to extracted DNA (Fig. 1B).
CCPP is known for its very high morbidity and high mortality
and for creating pathomorphologic lesions exhibiting effusions
with high concentrations of Mycoplasma isolates (in this case, we
evaluated 107 to 109 CCU/ml). Direct isolation and cultivation of
the causative bacteria from infected lung tissue samples or pleural
fluid samples taken postmortem are still the gold standard for the
diagnosis of CCPP. However, cultivation has limitations that are
exacerbated in resource-limited areas: it requires specialized nu-
trient media, takes several days, and is often unsuccessful due to
the fastidious nature of the organism. Currently available molec-
ular diagnostic tools employing PCR and LAMP require either a
well-equipped laboratory or extensive sample preparation, thus
limiting their application in the field. We have transcended the
limits of these assays and tests using an RPA-based field applicable
assay to detect M. capricolum subsp. capripneumoniae directly
from pleural fluid samples collected from infected animals. After
diluting the sample in nuclease-free water, we were able to detect
bacteria within 15 min (Fig. 2). Using this approach, a definitive
diagnosis of CCPP presence in a herd can be achieved in	45min.
In addition, we tested suitability for field applications of the
method by lyophilizing the RPA reactions and MgOAc and stor-
ing them at 4°C and 37°C. The fresh in-house lyophilized RPA
reagents had similar sensitivity as the fresh RPA reactions. How-
ever, after storage at 37°C for a few days, the in-house lyophilized
reagents lost activity completely. The lyophilized RPA reagents
can be stored at 4°C for 3 months and still maintain a detection
limit of 50 CCU/reaction. The pleural fluid from CCPP-positive
animals has a range of 107 to 109 CCU/ml; therefore, the lyophi-
lized RPA reactions should be able to detectM. capricolum subsp.
capripneumoniae from pleural fluid. The ESEQuant tube scanner
is portable and can be powered by a car battery. This equipment
has been distributed to 35 African countries and has been tested in
their respective laboratories (22). Thus, the method described is
suitable for rapid CCPP diagnosis in the field. The RPA reagents
can be lyophilized in the lab and transported to the field on an ice
pack, the reaction can be performed in a car, and the assay pro-
duces definitive results in	45min.Our results indicate that RPAs
are robust, rapid, specific, sensitive, and suitable for field applica-
tions. The use of other goat specimens, such as broncholavage and
nasal swabs, remains to be evaluated and optimized.
The assay we describe is based on a single-copy target region in
M. capricolum subsp. capripneumoniae. Ruminant Mycoplasma
strains have been reported to have minimal genomes that are able
to exchange DNA (23) through a conjugation-like process driven
by integrative conjugative elements (24). Therefore, it would be
advisable to havemultiple target regions to increase the specificity
of the assay. Additionally, the use of multicopy targets, if present,
should be considered in the future to increase the sensitivity.
The low temperature required for RPAmakes this CCPP assay
an excellent foundation for the development of a novel field-ap-
plicable diagnostic tool in which the assays are integrated into a
microfluidics platform and combined with a mobile phone-pow-
ered device which provides the temperature control for the assay
and measures assay florescence. We are currently working on a
related diagnostic platform. Importantly, this class of mobile as-
says that integrate mechanisms of data transmission can form the
backbone of a national early warning system for disease, in which
test data are disseminated through mobile phone apps.
In summary, this is the first description of an RPA-based field
applicable diagnostic assay for a disease caused by Mycoplasma
spp. Although this assay in moderately expensive, this technology
offers significant advantages regarding speed and the potential for
conversion into a next-generation diagnostic assay that is con-
nected to mobile phone technology in resource-poor settings,
such as sub-Saharan Africa and Asia.
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